Investment
Features
FeesSafety
Academy
More
Pluang+

Igloo to shut down Abstract blockchain Dec 15, 2026; PENGU token holders must move assets to avoid loss.

Protocol Fundamentals
14 Oct 2026
CryptoTicker
View Source
Bearish
Igloo to shut down Abstract blockchain Dec 15, 2026; PENGU token holders must move assets to avoid loss.

Igloo, the company behind Pudgy Penguins, announced it will shut down its Abstract layer-2 blockchain on December 15, 2026. Holders of the PENGU token and Pudgy Penguins NFTs on Abstract must move their assets before this deadline or risk losing access. Despite processing over 325 million transactions and hosting major brands, Abstract was not commercially viable, leading Igloo to focus on the Pudgy Penguins brand and physical products instead. Token holders should use official migration tools and be aware of tax implications when transferring assets to other blockchains.

The Pudgy Penguins project and its PENGU token face a key deadline as the Abstract layer-2 blockchain will shut down on December 15, 2026. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 14, 2026 16:31 WIB: out of 50 major cryptocurrencies, 13 rose and 36 fell today. Notable movers include SAND (The Sandbox) at Rp1.030 with a 10% Sell / 90% Buy order activity, COTI at Rp221 with 25% Sell / 75% Buy, and CAKE (PancakeSwap) at Rp42.684 with 17% Sell / 83% Buy.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App